These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22302315)

  • 1. Campylobacter fetus infection in three rheumatoid arthritis patients treated with rituximab.
    Meyer A; Theulin A; Chatelus E; Argemi X; Sordet C; Javier RM; Hansmann Y; Sibilia J; Gottenberg JE
    Ann Rheum Dis; 2012 Jun; 71(6):1094-5. PubMed ID: 22302315
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe Pasteurella multocida infection in a patient on rituximab therapy for rheumatoid arthritis.
    Rouil A; Pollet S; Martin A; Tattevin P; Perdriger A
    Joint Bone Spine; 2013 Mar; 80(2):224-5. PubMed ID: 23477740
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritis.
    Vallet H; Houitte R; Azria A; Mariette X
    J Rheumatol; 2011 May; 38(5):965-6. PubMed ID: 21532065
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheumatoid arthritis, alveolar echinococcosis, and rituximab: a case report.
    Dentan C; Mazet R; Gilson M; Marchou-Lopez S; Gaudin P
    Joint Bone Spine; 2012 May; 79(3):325-7. PubMed ID: 22154698
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent fever caused by Candidatus Neoehrlichia mikurensis in a rheumatoid arthritis patient treated with rituximab.
    Andréasson K; Jönsson G; Lindell P; Gülfe A; Ingvarsson R; Lindqvist E; Saxne T; Grankvist A; Wennerås C; Marsal J
    Rheumatology (Oxford); 2015 Feb; 54(2):369-71. PubMed ID: 25416710
    [No Abstract]   [Full Text] [Related]  

  • 6. Late-onset neutropenia in patients with rheumatoid arthritis after treatment with rituximab.
    Abdulkader R; Dharmapalaiah C; Rose G; Shand LM; Clunie GP; Watts RA
    J Rheumatol; 2014 May; 41(5):858-61. PubMed ID: 24634201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is an extra dose of rituximab an efficacious and safe alternative to improve outcomes in rheumatoid arthritis? Comment on the article by Vital et al.
    Bredemeier M
    Ann Rheum Dis; 2014 Jun; 73(6):e33. PubMed ID: 24595549
    [No Abstract]   [Full Text] [Related]  

  • 8. Cryptococcal meningitis in an HIV-negative patient with rheumatoid arthritis treated with rituximab.
    Wingfield T; Jani M; Krutikov M; Mayer J; Uriel A; Marks J; Ustianowski AP
    Rheumatology (Oxford); 2011 Sep; 50(9):1725-7. PubMed ID: 21700684
    [No Abstract]   [Full Text] [Related]  

  • 9. Plantar pustulosis during rituximab therapy for rheumatoid arthritis.
    Brunasso AM; Massone C
    J Am Acad Dermatol; 2012 Oct; 67(4):e148-50. PubMed ID: 22980273
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological treatment of rheumatoid arthritis: towards a more cost-effective re-treatment regimen using rituximab?
    Boumans MJ; Vos K; Gerlag DM; Tak PP
    Ann Rheum Dis; 2012 Mar; 71(3):472-3. PubMed ID: 21908451
    [No Abstract]   [Full Text] [Related]  

  • 11. Can response duration after the first rituximab treatment be used in timing of rituximab retreatment?
    van Herwaarden N; van der Maas A; Jansen TL; Dutmer EA; Hartkamp A; van Riel PL; Kievit W; van den Bemt BJ; den Broeder AA
    Scand J Rheumatol; 2013; 42(3):251-2. PubMed ID: 23496283
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical psoriasis following rituximab for rheumatoid arthritis.
    Hardcastle SA; Gibbs S; Williamson L
    J Rheumatol; 2012 Jun; 39(6):1303-4. PubMed ID: 22661424
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis.
    Willeke P; Becker H; Schlüter B; Pavenstäd H; Mickholz E; Wierichs C; Gaubitz M; Schotte H
    Scand J Rheumatol; 2012 May; 41(3):242-3. PubMed ID: 22401537
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum sickness and severe angioedema following rituximab therapy in RA.
    Kumar A; Khamkar K; Gopal H
    Int J Rheum Dis; 2012 Feb; 15(1):e6-7. PubMed ID: 22324965
    [No Abstract]   [Full Text] [Related]  

  • 15. Prompt efficacy of very low-dose rituximab on monoclonal B lymphocytosis in a rheumatoid arthritis patient.
    Bruzzese V; Marrese C; Hassan C; Andriani A; Zullo A
    Int J Rheum Dis; 2013 Dec; 16(6):764-5. PubMed ID: 24200218
    [No Abstract]   [Full Text] [Related]  

  • 16. B-cell therapies in established rheumatoid arthritis.
    Leandro MJ; Becerra-Fernandez E
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):535-48. PubMed ID: 22137923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate.
    Lutman C; Finocchiaro G; Abate E; Milo M; Morassi P; Sinagra G
    J Cardiovasc Med (Hagerstown); 2014 Dec; 15(12):880-2. PubMed ID: 25083725
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab treatment for persistent scleritis associated with rheumatoid arthritis.
    Iaccheri B; Androudi S; Bocci EB; Gerli R; Cagini C; Fiore T
    Ocul Immunol Inflamm; 2010 Jun; 18(3):223-5. PubMed ID: 20482403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center.
    Besada E; Koldingsnes W; Nossent J
    QJM; 2012 Jun; 105(6):545-50. PubMed ID: 22301823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of bilateral peripheral ulcerative keratitis following treatment with rituximab.
    Goodisson LA; Bourne JT; Maharajan S
    Rheumatology (Oxford); 2010 Mar; 49(3):609-10. PubMed ID: 19946020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.